- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01083407
Oral Care Interventions and Ventilator Associated Pneumonia in Critically Ill Children
Oral Care Interventions With 0.12% Chlorhexidine and Ventilator Associated Pneumonia in Critically Ill Children: Prospective, Randomic and Double Blind Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Recent progress in identification of oral microorganisms has shown that the oropharynx can be a site of origin for dissemination of pathogenic organisms to distant body sites, such as the lungs. THe aims of the study were to compare the oropharyngeal microbiological profile, VAP incidence, duration of mechanical ventilation, and length of stay in the intensive care unit of children receiving mechanical ventilation who had pharmacological or nonpharmacological oral care.
A randomized and controlled study has been performed in a pediatric intensive unit in São Paulo, Brazil. The children are randomly assigned to an experimental group that received oral care with use of 0.12% chlorhexidine digluconate or a control group that received oral care without an antiseptic. Oropharyngeal and tracheal secretions were collected and cultured on days 0, 2, and 4, and at discharge.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Critically ill children.
- Age: 29 days to 18 years.
Exclusion Criteria:
- Newborn age.
- Pneumonia at PICU admission.
- Tracheostomy.
- Tracheal intubation higher than 24 hours in the PICU admission.
- PICU LOS lower than 48 hours.
- Responsibles declined consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 0.12% Chlorhexidie Digluconate
Oral care included use of an oral gel containing chlorhexidine digluconate 0.12% as an active ingredient (chlorhexidine digluconate 0.12%; methylcellulose gel 2.12%, 25 g; gooseberry syrup, 4 drops; menthol solution 50%,3 drops; and distilled water, to 30 g).The gel is applied on a toothbrush, and the teeth are cleaned in quadrants; all teeth surfaces are cleaned (vestibular,lingual, occlusal, and incisal).
After each quadrant was cleaned, 10 mL of water (dispensed via a syringe) is used to rinse the quadrant and continual aspiration is used to remove all the gel and debris.
After all the teeth are cleaned, the ventral surface of the tongue is brushed with posteriorto- anterior movements.
|
Oral care with 0.12% Chlorhexidine Digluconate and toothbrushing is realized twice a day and took about 10 minutes to complete, depending on the child's acceptance and clinical conditions.
|
Placebo Comparator: Toothbrushing
This group received the same oral care that experimental group with the use of a similarly formulated gel without the antiseptic agent.The gel is applied on a toothbrush, and the teeth are cleaned in quadrants; all teeth surfaces are cleaned (vestibular, lingual, occlusal, and incisal).
After each quadrant is cleaned, 10 mL of water (dispensed via a syringe) is used to rinse the quadrant and continual aspiration is used to remove all the gel and debris.
After all the teeth are cleaned, the ventral surface of the tongue is brushed with posteriorto-anterior movements.
|
Gel is applied on a toothbrush, and the teeth are cleaned in quadrants; all teeth surfaces are cleaned (vestibular, lingual, occlusal, and incisal).
After each quadrant is cleaned, 10 mL of water (dispensed via a syringe) is used to rinse the quadrant and continual aspiration is used to remove all the gel and debris.
After all the teeth are cleaned, the ventral surface of the tongue is brushed with posteriorto-anterior movements.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ventilator associated pneumonia
Time Frame: 48 hours after tracheal intubation
|
Influence of oral care with 0.12% chlorhexidine on VAP incidence diagnosed by clinical pulmonary infection score.
|
48 hours after tracheal intubation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PICU Lengh of Stay
Time Frame: Necessary days to PICU discharge
|
Influence of oral care with 0.12% chlorhexidine on PICU LOS
|
Necessary days to PICU discharge
|
Time of Mechanical pulmonary ventilation
Time Frame: Last day of MPV
|
Influence of oral care with 0.12% chlorhexidine on time of mechanical ventilation.
|
Last day of MPV
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Lung Diseases
- Disease Attributes
- Cross Infection
- Iatrogenic Disease
- Healthcare-Associated Pneumonia
- Pneumonia
- Pneumonia, Ventilator-Associated
- Anti-Infective Agents, Local
- Anti-Infective Agents
- Dermatologic Agents
- Disinfectants
- Chlorhexidine
- Chlorhexidine gluconate
Other Study ID Numbers
- Oral care and VAP in children.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventilator Associated Pneumonia
-
Hospital Alemão Oswaldo CruzMinistry of Health, BrazilRecruitingHealthcare-Associated Pneumonia | Ventilator-Associated Pneumonia | Healthcare Associated InfectionBrazil
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Cubist Pharmaceuticals LLCCompletedLung Diseases | Healthcare-Associated Pneumonia | Ventilator-Associated Pneumonia
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
University Hospital OlomoucCompletedVentilator-Associated Pneumonia
-
Aydin Adnan Menderes UniversityNot yet recruitingVentilator-Associated PneumoniaTurkey
-
Istanbul Medeniyet UniversityRecruiting
-
University Hospital, ToulouseRecruitingVentilator-associated PneumoniaFrance
-
Erasmus Medical CenterChiesi Farmaceutici S.p.A.CompletedVentilator Associated Pneumonia (VAP)Spain, Netherlands
-
Andrzej Frycz Modrzewski Krakow UniversityCompletedVAP - Ventilator Associated PneumoniaPoland
Clinical Trials on 0.12% Chlorhexidine Digluconate
-
University of TaubateConselho Nacional de Desenvolvimento Científico e TecnológicoUnknownPeriodontitis | Normal Blood PressureBrazil
-
Aravena, Pedro, DDS, PhDUniversidad Austral de ChileCompleted
-
Technische Universität DresdenCompletedDiscoloration of TeethGermany
-
University of MilanCompleted
-
University of OsloUnknown
-
University of OsloGöteborg UniversityCompletedDental Caries | Periodontal Disease
-
University of LjubljanaCompleted
-
National and Kapodistrian University of AthensCompletedPeriodontitis | Wound Healing
-
Universidad de GuanajuatoUnknownVentilator Associated Pneumonia | ChlorhexidineMexico